{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:17:39Z","timestamp":1788304659426,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":80,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_17","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:58:35Z","timestamp":1788303515000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examination of Antigen-Specific B Cell Responses to Red Blood Cell Transfusion"],"prefix":"10.1007","author":[{"given":"Leon","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Oehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Jajosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"17_CR1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","volume":"120","author":"K Yazdanbakhsh","year":"2012","unstructured":"Yazdanbakhsh K, Ware RE, Noizat-Pirenne F (2012) Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 120(3):528\u2013537","journal-title":"Blood"},{"issue":"6","key":"17_CR2","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","volume":"10","author":"F Pirenne","year":"2023","unstructured":"Pirenne F, Floch A, Diop S (2023) Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries. Lancet Haematol 10(6):e468\u2013e476","journal-title":"Lancet Haematol"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","volume":"18","author":"CM Arthur","year":"2023","unstructured":"Arthur CM, Stowell SR (2023) The development and consequences of red blood cell alloimmunization. Annu Rev Pathol 18:537\u2013564","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"17_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/trf.15718","volume":"60","author":"RG Hauser","year":"2020","unstructured":"Hauser RG et al (2020) The evanescence and persistence of RBC alloantibodies in blood donors. Transfusion 60(4):831\u2013839","journal-title":"Transfusion"},{"issue":"17","key":"17_CR5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","volume":"133","author":"CA Tormey","year":"2019","unstructured":"Tormey CA, Hendrickson JE (2019) Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 133(17):1821\u20131830","journal-title":"Blood"},{"issue":"1","key":"17_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/voxs.12296","volume":"12","author":"K Yazdanbakhsh","year":"2017","unstructured":"Yazdanbakhsh K, Shaz BH, Hillyer CD (2017) Immune regulation of sickle cell alloimmunization. ISBT Sci Ser 12(1):248\u2013253","journal-title":"ISBT Sci Ser"},{"issue":"4","key":"17_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101704","volume":"298","author":"AV Blenda","year":"2022","unstructured":"Blenda AV et al (2022) Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens. J Biol Chem 298(4):101704","journal-title":"J Biol Chem"},{"issue":"5","key":"17_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100747","volume":"23","author":"HM Jan","year":"2024","unstructured":"Jan HM et al (2024) Galectin-4 antimicrobial activity primarily occurs through its C-terminal domain. Mol Cell Proteomics 23(5):100747","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"17_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104482","volume":"25","author":"SC Wu","year":"2022","unstructured":"Wu SC et al (2022) Innate immune Galectin-7 specifically targets microbes that decorate themselves in blood group-like antigens. iScience 25(7):104482","journal-title":"iScience"},{"issue":"3","key":"17_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3324\/haematol.2019.224709","volume":"105","author":"SL Thein","year":"2020","unstructured":"Thein SL et al (2020) Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica 105(3):539\u2013544","journal-title":"Haematologica"},{"issue":"1","key":"17_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/trf.13270","volume":"56","author":"HR Waterman","year":"2016","unstructured":"Waterman HR et al (2016) Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions. Transfusion 56(1):91\u2013100","journal-title":"Transfusion"},{"issue":"23","key":"17_CR12","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia a. Blood 130(23):2559\u20132568","journal-title":"Blood"},{"issue":"14","key":"17_CR13","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","volume":"127","author":"CM Arthur","year":"2016","unstructured":"Arthur CM et al (2016) CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood 127(14):1823\u20131827","journal-title":"Blood"},{"issue":"9","key":"17_CR14","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139(9):1312\u20131317","journal-title":"Blood"},{"issue":"8","key":"17_CR15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/trf.16967","volume":"62","author":"ML Covington","year":"2022","unstructured":"Covington ML et al (2022) Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: challenges and opportunities for improvement. Transfusion 62(8):1662\u20131670","journal-title":"Transfusion"},{"issue":"10","key":"17_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ajh.24460","volume":"91","author":"A Habibi","year":"2016","unstructured":"Habibi A et al (2016) Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. Am J Hematol 91(10):989\u2013994","journal-title":"Am J Hematol"},{"issue":"12","key":"17_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/ajh.24908","volume":"92","author":"D Narbey","year":"2017","unstructured":"Narbey D et al (2017) Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease. Am J Hematol 92(12):1340\u20131348","journal-title":"Am J Hematol"},{"issue":"2","key":"17_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tracli.2019.03.002","volume":"26","author":"S Chonat","year":"2019","unstructured":"Chonat S et al (2019) Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Transfus Clin Biol 26(2):130\u2013134","journal-title":"Transfus Clin Biol"},{"issue":"11","key":"17_CR19","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1172\/JCI64578","volume":"123","author":"S Ghosh","year":"2013","unstructured":"Ghosh S et al (2013) Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest 123(11):4809\u20134820","journal-title":"J Clin Invest"},{"issue":"4","key":"17_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tmrv.2019.09.007","volume":"33","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Bartolucci P, Pirenne F (2019) The role of complement in post-transfusion hemolysis and hyperhemolysis reaction. Transfus Med Rev 33(4):225\u2013230","journal-title":"Transfus Med Rev"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3389\/fimmu.2020.01684","volume":"11","author":"V Poillerat","year":"2020","unstructured":"Poillerat V et al (2020) Hemopexin as an inhibitor of hemolysis-induced complement activation. Front Immunol 11:1684","journal-title":"Front Immunol"},{"key":"17_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901876","volume":"13","author":"A Gerogianni","year":"2022","unstructured":"Gerogianni A et al (2022) Heme interferes with complement factor I-dependent regulation by enhancing alternative pathway activation. Front Immunol 13:901876","journal-title":"Front Immunol"},{"issue":"2","key":"17_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","volume":"26","author":"NS Merle","year":"2019","unstructured":"Merle NS et al (2019) Complement activation during intravascular hemolysis: implication for sickle cell disease and hemolytic transfusion reactions. Transfus Clin Biol 26(2):116\u2013124","journal-title":"Transfus Clin Biol"},{"issue":"13","key":"17_CR24","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1073\/pnas.1814797116","volume":"116","author":"NS Merle","year":"2019","unstructured":"Merle NS et al (2019) P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4\/heme-dependent manner. Proc Natl Acad Sci USA 116(13):6280\u20136285","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"17_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104205","volume":"52","author":"MS Meuleman","year":"2023","unstructured":"Meuleman MS, Roumenina LT, Grunenwald A (2023) Complement involvement in sickle cell disease. Presse Med 52(4):104205","journal-title":"Presse Med"},{"issue":"8","key":"17_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","volume":"127","author":"G Dumas","year":"2016","unstructured":"Dumas G et al (2016) Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 127(8):1062\u20131064","journal-title":"Blood"},{"issue":"10","key":"17_CR27","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","volume":"103","author":"S Chonat","year":"2018","unstructured":"Chonat S et al (2018) Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 103(10):e483\u2013e485","journal-title":"Haematologica"},{"issue":"807","key":"17_CR28","doi-asserted-by":"publisher","first-page":"eadl4922","DOI":"10.1126\/scitranslmed.adl4922","volume":"17","author":"S Chonat","year":"2025","unstructured":"Chonat S et al (2025) Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Sci Transl Med 17(807):eadl4922","journal-title":"Sci Transl Med"},{"issue":"23","key":"17_CR29","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","volume":"322","author":"EP Vichinsky","year":"1990","unstructured":"Vichinsky EP et al (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322(23):1617\u20131621","journal-title":"N Engl J Med"},{"issue":"6","key":"17_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","volume":"122","author":"ST Chou","year":"2013","unstructured":"Chou ST et al (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122(6):1062\u20131071","journal-title":"Blood"},{"issue":"3","key":"17_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/trf.17740","volume":"64","author":"N Israelyan","year":"2024","unstructured":"Israelyan N et al (2024) RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: a multisite study in the USA. Transfusion 64(3):526\u2013535","journal-title":"Transfusion"},{"key":"17_CR32","doi-asserted-by":"crossref","unstructured":"Wolf J et al (2024) Red cell specifications for blood group matching in patients with haemoglobinopathies: an updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines. Br J Haematol","DOI":"10.1111\/bjh.19837"},{"issue":"1","key":"17_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4049\/jimmunol.1400105","volume":"193","author":"H Zhong","year":"2014","unstructured":"Zhong H et al (2014) Hemin controls T cell polarization in sickle cell alloimmunization. J Immunol 193(1):102\u2013110","journal-title":"J Immunol"},{"issue":"9","key":"17_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3324\/haematol.2016.147181","volume":"101","author":"E Godefroy","year":"2016","unstructured":"Godefroy E et al (2016) Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization. Haematologica 101(9):1028\u20131038","journal-title":"Haematologica"},{"issue":"13","key":"17_CR35","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1182\/blood.2021011629","volume":"138","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease. Blood 138(13):1162\u20131171","journal-title":"Blood"},{"issue":"6","key":"17_CR36","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/eji.201445187","volume":"45","author":"B Vingert","year":"2015","unstructured":"Vingert B et al (2015) Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients. Eur J Immunol 45(6):1868\u20131879","journal-title":"Eur J Immunol"},{"issue":"8","key":"17_CR37","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.3324\/haematol.2016.162685","volume":"102","author":"D Evers","year":"2017","unstructured":"Evers D et al (2017) Absence of the spleen and the occurrence of primary red cell alloimmunization in humans. Haematologica 102(8):e289\u2013e292","journal-title":"Haematologica"},{"issue":"3","key":"17_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tracli.2015.05.005","volume":"22","author":"K Yazdanbakhsh","year":"2015","unstructured":"Yazdanbakhsh K (2015) Mechanisms of sickle cell alloimmunization. Transfus Clin Biol 22(3):178\u2013181","journal-title":"Transfus Clin Biol"},{"issue":"5","key":"17_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/bjh.18899","volume":"202","author":"H Nakahara","year":"2023","unstructured":"Nakahara H et al (2023) Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease. Br J Haematol 202(5):937\u2013941","journal-title":"Br J Haematol"},{"issue":"17","key":"17_CR40","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1182\/bloodadvances.2022008647","volume":"7","author":"Y Zheng","year":"2023","unstructured":"Zheng Y et al (2023) Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease. Blood Adv 7(17):4799\u20134808","journal-title":"Blood Adv"},{"issue":"8","key":"17_CR41","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","volume":"122","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model. Blood 122(8):1494\u20131504","journal-title":"Blood"},{"issue":"11","key":"17_CR42","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","volume":"101","author":"A Arneja","year":"2016","unstructured":"Arneja A et al (2016) Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica 101(11):e440\u2013e444","journal-title":"Haematologica"},{"issue":"12","key":"17_CR43","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/j.1537-2995.2012.03641.x","volume":"52","author":"NH Smith","year":"2012","unstructured":"Smith NH et al (2012) Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 52(12):2620\u20132630","journal-title":"Transfusion"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"1548548","DOI":"10.3389\/fimmu.2025.1548548","volume":"16","author":"RP Jajosky","year":"2025","unstructured":"Jajosky RP et al (2025) CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion. Front Immunol 16:1548548","journal-title":"Front Immunol"},{"key":"17_CR45","doi-asserted-by":"crossref","unstructured":"Mener A et al (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight 3(22)","DOI":"10.1172\/jci.insight.121631"},{"issue":"2","key":"17_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/bloodadvances.2017010124","volume":"2","author":"SR Patel","year":"2018","unstructured":"Patel SR et al (2018) Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice. Blood Adv 2(2):105\u2013115","journal-title":"Blood Adv"},{"issue":"6","key":"17_CR47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjh.15998","volume":"186","author":"SM Meinderts","year":"2019","unstructured":"Meinderts SM et al (2019) Identification of genetic biomarkers for alloimmunization in sickle cell disease. Br J Haematol 186(6):887\u2013899","journal-title":"Br J Haematol"},{"issue":"21","key":"17_CR48","first-page":"2642","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R et al (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141(21):2642\u20132653","journal-title":"Blood"},{"issue":"8","key":"17_CR49","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/j.1537-2995.2009.02200.x","volume":"49","author":"JE Hendrickson","year":"2009","unstructured":"Hendrickson JE et al (2009) The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion 49(8):1678\u20131684","journal-title":"Transfusion"},{"issue":"9","key":"17_CR50","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","volume":"46","author":"JE Hendrickson","year":"2006","unstructured":"Hendrickson JE et al (2006) Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 46(9):1526\u20131536","journal-title":"Transfusion"},{"issue":"2","key":"17_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1537-2995.2011.03255.x","volume":"52","author":"JE Hendrickson","year":"2012","unstructured":"Hendrickson JE et al (2012) Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Transfusion 52(2):231\u2013240","journal-title":"Transfusion"},{"issue":"5","key":"17_CR52","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/trf.16872","volume":"62","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion 62(5):948\u2013953","journal-title":"Transfusion"},{"issue":"3","key":"17_CR53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/trf.17251","volume":"63","author":"CL Maier","year":"2023","unstructured":"Maier CL et al (2023) Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice. Transfusion 63(3):457\u2013462","journal-title":"Transfusion"},{"issue":"7","key":"17_CR54","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","volume":"198","author":"CM Arthur","year":"2017","unstructured":"Arthur CM et al (2017) Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol 198(7):2671\u20132680","journal-title":"J Immunol"},{"issue":"6","key":"17_CR55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000368995","volume":"41","author":"AB Ryder","year":"2014","unstructured":"Ryder AB, Zimring JC, Hendrickson JE (2014) Factors influencing RBC alloimmunization: lessons learned from murine models. Transfus Med Hemother 41(6):406\u2013419","journal-title":"Transfus Med Hemother"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3389\/fimmu.2018.00676","volume":"9","author":"A Mener","year":"2018","unstructured":"Mener A et al (2018) Complement component 3 negatively regulates antibody response by modulation of red blood cell antigen. Front Immunol 9:676","journal-title":"Front Immunol"},{"issue":"8","key":"17_CR57","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1182\/bloodadvances.2022008411","volume":"7","author":"A Couvidou","year":"2023","unstructured":"Couvidou A et al (2023) Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice. Blood Adv 7(8):1356\u20131365","journal-title":"Blood Adv"},{"issue":"6","key":"17_CR58","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/TP.0000000000004931","volume":"108","author":"MA Kallarakal","year":"2024","unstructured":"Kallarakal MA et al (2024) Marginal zone B cells are necessary for the formation of anti-donor IgG after allogeneic sensitization. Transplantation 108(6):1357\u20131367","journal-title":"Transplantation"},{"issue":"3","key":"17_CR59","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood-2005-03-1040","volume":"106","author":"JC Zimring","year":"2005","unstructured":"Zimring JC et al (2005) Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 106(3):1105\u20131112","journal-title":"Blood"},{"issue":"6","key":"17_CR60","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","volume":"110","author":"JC Zimring","year":"2007","unstructured":"Zimring JC et al (2007) Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 110(6):2201\u20132208","journal-title":"Blood"},{"issue":"3","key":"17_CR61","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","volume":"112","author":"EA Hod","year":"2008","unstructured":"Hod EA et al (2008) Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 112(3):891\u2013894","journal-title":"Blood"},{"issue":"12","key":"17_CR62","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","volume":"52","author":"JS Liepkalns","year":"2012","unstructured":"Liepkalns JS et al (2012) Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion 52(12):2631\u20132645","journal-title":"Transfusion"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathol-012414-040318","volume":"10","author":"JC Zimring","year":"2015","unstructured":"Zimring JC, Spitalnik SL (2015) Pathobiology of transfusion reactions. Annu Rev Pathol 10:83\u2013110","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"17_CR64","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1182\/bloodadvances.2020002695","volume":"5","author":"CM Arthur","year":"2021","unstructured":"Arthur CM et al (2021) Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Adv 5(2):527\u2013538","journal-title":"Blood Adv"},{"issue":"10","key":"17_CR65","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","volume":"191","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation. J Immunol 191(10):5013\u20135025","journal-title":"J Immunol"},{"issue":"10","key":"17_CR66","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","volume":"122","author":"KR Girard-Pierce","year":"2013","unstructured":"Girard-Pierce KR et al (2013) A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation. Blood 122(10):1793\u20131801","journal-title":"Blood"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"1548548","DOI":"10.3389\/fimmu.2025.1548548","volume":"16","author":"RP Jajosky","year":"2025","unstructured":"Jajosky RP, Covington ML, Liu J, Chai L, Zerra PE, Chonat S, Stowell SR, Arthur CM (2025) CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion. Front Immunol 16:1548548","journal-title":"Front Immunol"},{"issue":"4","key":"17_CR68","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/trf.17284","volume":"63","author":"H Wabnitz","year":"2023","unstructured":"Wabnitz H, Cruz-Leal Y, Lazarus AH (2023) Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model. Transfusion 63(4):696\u2013702","journal-title":"Transfusion"},{"issue":"6","key":"17_CR69","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.4049\/jimmunol.1302287","volume":"193","author":"H Yu","year":"2014","unstructured":"Yu H et al (2014) Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. J Immunol 193(6):2902\u20132910","journal-title":"J Immunol"},{"issue":"9","key":"17_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1182\/blood.2023020860","volume":"143","author":"Y Cruz-Leal","year":"2024","unstructured":"Cruz-Leal Y et al (2024) Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression. Blood 143(9):807\u2013821","journal-title":"Blood"},{"key":"17_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972723","volume":"13","author":"A Qiu","year":"2022","unstructured":"Qiu A et al (2022) FcgammaRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Front Immunol 13:972723","journal-title":"Front Immunol"},{"key":"17_CR72","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fimmu.2020.01516","volume":"11","author":"P Shinde","year":"2020","unstructured":"Shinde P et al (2020) IgG subclass determines suppression versus enhancement of humoral alloimmunity to Kell RBC antigens in mice. Front Immunol 11:1516","journal-title":"Front Immunol"},{"key":"17_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629608","volume":"12","author":"A Jash","year":"2021","unstructured":"Jash A et al (2021) Antibodies to low-copy number RBC alloantigen convert a tolerogenic stimulus to an immunogenic stimulus in mice. Front Immunol 12:629608","journal-title":"Front Immunol"},{"key":"17_CR74","doi-asserted-by":"crossref","unstructured":"Jash A et al (2024) Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. J Clin Invest 134(8)","DOI":"10.1172\/JCI167665"},{"issue":"5","key":"17_CR75","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.4049\/jimmunol.1500790","volume":"195","author":"L Bernardo","year":"2015","unstructured":"Bernardo L et al (2015) IgG-mediated immune suppression to erythrocytes by polyclonal antibodies can occur in the absence of activating or inhibitory Fcgamma receptors in a full mouse model. J Immunol 195(5):2224\u20132230","journal-title":"J Immunol"},{"issue":"12","key":"17_CR76","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142(12):1082\u20131098","journal-title":"Blood"},{"issue":"21","key":"17_CR77","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","volume":"2","author":"CL Maier","year":"2018","unstructured":"Maier CL et al (2018) Antibody-mediated immune suppression by antigen modulation is antigen-specific. Blood Adv 2(21):2986\u20133000","journal-title":"Blood Adv"},{"key":"17_CR78","doi-asserted-by":"publisher","first-page":"1475470","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP et al (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol 15:1475470","journal-title":"Front Immunol"},{"issue":"8","key":"17_CR79","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2020009376","volume":"138","author":"PE Zerra","year":"2021","unstructured":"Zerra PE et al (2021) Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice. Blood 138(8):706\u2013721","journal-title":"Blood"},{"issue":"3","key":"17_CR80","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41596-023-00930-8","volume":"19","author":"A Phelps","year":"2024","unstructured":"Phelps A et al (2024) Production and use of antigen tetramers to study antigen-specific B cells. Nat Protoc 19(3):727\u2013751","journal-title":"Nat Protoc"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:58:36Z","timestamp":1788303516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}